Pain Therapeutics
Pain Therapeutics, Inc.
2211 Bridgepointe Parkway Suite 500, San Mateo, CA 94404
Phone: (650) 624-8200 Website: https://www.cassavasciences.com/
Latest news
- Pain Therapeutics Announces Feedback from Recent Meeting With FDA on Remoxy
5 February 2019 - Complete Response Letter Issued for Remoxy
6 August 2018 - Pain Therapeutics Announces Results of FDA Advisory Committee Meeting for Remoxy ER
26 June 2018 - FDA Accepts Remoxy NDA For Review
1 March 2018 - Pain Therapeutics Resubmits New Drug Application for Remoxy ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic Pain
13 February 2018 - Pain Therapeutics Receives Complete Response Letter for Remoxy ER
26 September 2016 - FDA Accepts Remoxy NDA for Review
12 April 2016 - Pain Therapeutics Resubmits Remoxy New Drug Application to the U.S. Food and Drug Administration
29 March 2016 - Pfizer to Discontinue Agreement on Remoxy (oxycodone) Extended-Release Capsules CII
27 October 2014 - FDA Complete Response Letter Received for Remoxy
24 June 2011
